Pharma Reviews: Pharma companies face spurt in regulatory issues from US health regulator

“As we (Indian pharma industry) produce more and more volumes, issues tend to come up. Most of the issues being raised by the USFDA are only ...
Read more: Pharma companies face spurt in regulatory issues from US health regulator